Loading company…
Riskpilot
← Back to search
Sign in
Get full access
V-BIOTEK AF 5. SEPTEMBER 2014 ApS
APS
Bankrupt
CVR 30525701
Vimmelskaftet 43
Forskning og eksperimentel udvikling indenfor bioteknologi · NACE 721100
Est. 2008
— employees
Watchlist
Share
Overview
Financials
People & ownership
Related companies
Revenue 2014
DKK -6K
-77% vs 2013
EBITDA margin
66969.6%
-15303% vs 2013
Equity ratio
-3485.2%
Financial strength
Net profit 2014
DKK -4,6M
-18303% vs 2013
EBITDA — year on year
DKK millions
0M
-1M
-3M
-4M
-5M
0M
2012
0M
0%
2013
-4M
-400%
2014
Key figures
Annual report 2014
Revenue
DKK -6K
-77%
EBITDA
DKK -3,9M
-15303%
Net profit
DKK -4,6M
-18303%
Total assets
DKK 130K
-97%
Equity
DKK -4,5M
-6572%
Employees
—
—
Company information
Legal name
V-BIOTEK AF 5. SEPTEMBER 2014 ApS
CVR number
30525701
Legal form
Anpartsselskab
NACE code
721100 · Forskning og eksperimentel udvikling indenfor bioteknologi
Founded
21. april 2008
Share capital
DKK 125.000
Employees
—
VAT registered
No
Audit selected
No
Last report
2014-06-30
Financial year
January – December
Signatory rights
Virksomheden tegnes af en likvidator
Contact
Address
Vimmelskaftet 43
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
Visit risika.com
Explore
Companies in Forskning og eksperimentel udvikling indenfor bioteknologi
Companies in København
All Denmark companies
Revenue
DKK millions
0M
0M
1M
1M
1M
0M
2012
0M
2013
0M
2014
EBITDA
DKK millions
0M
0M
1M
1M
1M
0M
2012
0M
2013
-4M
2014
Income statement
DKK thousands
Item
2012
2013
2014
Revenue
-5
-25
-6
Staff expenses
-0
-0
-0
EBITDA
-5
-25
-3.851
Depreciation & amort.
-0
-0
-0
EBIT
-5
-25
-3.851
Net financials
0
0
-750
Profit before tax
-5
-25
-4.601
Tax
-0
-0
-0
Net profit
-5
-25
-4.601
Balance sheet
DKK thousands
Item
2012
2013
2014
Total assets
4.725
4.730
130
Equity
95
70
-4.531
Long-term debt
0
0
15
Short-term debt
4.630
4.660
4.661
Total debt
4.630
4.660
4.661
Financial ratios
5-year trend
EBITDA margin
-385075000.0%
This company
15.8%
Market median
-2437183644% vs market
2012
2014
Equity ratio
-3485.2%
This company
38.2%
Market median
-9224% vs market
2012
2014
Return on equity
-460075000.0%
This company
18.4%
Market median
-2500407709% vs market
2012
2014
Net profit margin
-460075000.0%
This company
8.1%
Market median
-5679938372% vs market
2012
2014
Asset turnover
-0.04×
This company
1.12×
Market median
-104% vs market
2012
2014
Debt / equity
1.03×
This company
0.62×
Market median
-66% vs market
2012
2014
Annual reports & filings
Annual report 2014
Filed via CVR / Virk · Period 2013-07-01 – 2014-06-30
View
PDF
Annual report 2013
Filed via CVR / Virk · Period 2012-07-01 – 2013-06-30
View
PDF
Annual report 2012
Filed via CVR / Virk · Period 2011-07-01 – 2012-06-30
View
PDF
Management
Actively employed in the business
Name
Role
Member since
Former (3)
HS
Henrik Sjørslev
Unofficial title
Unofficial title
2016 – 2016
AS
Annemarie Steen Olsen
Management
Management
2011 – 2014
JS
Jens Steen Olsen
Chief Executive Officer
Chief Executive Officer
2014 – 2016
Board of directors
Non-executive oversight
No data on file.
Shareholders
As of last annual report
Shareholder
Type
Ownership
Votes
Since
Fenucure Medical ApS
Company
100%
100%
2008
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
Company hierarchy
No registered parent or subsidiaries
Board network connections
Board members of V-BIOTEK AF 5. SEPTEMBER 2014 ApS also hold positions in
0
other companies.
Person
Role here
Other companies
Henrik Sjørslev
Unofficial title
0 companies
Annemarie Steen Olsen
Management
0 companies
Jens Steen Olsen
Chief Executive Officer
0 companies